Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • OBAGI MEDICAL PRODUCTS INC Analyst Recommendations

  • Analyst Consensus: OMPI

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 1.875 Buy 8
    30 Days Ago 1.875 Buy 8
    60 Days Ago 2.000 Buy 7
    90 Days Ago 2.000 Buy 7
    120 Days Ago 2.143 Buy 7

  • Analyst Ratings: OMPI

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Canaccord Adams — Buy 09/30/2009 —
    Brean Murray — Buy 08/19/2009 12.00
    Piper Jaffray Overweight Neutral 08/10/2009 —
    Robert W. Baird Neutral Outperform 08/06/2009 10.00
    Piper Jaffray — Overweight 07/07/2009 9.00
    Thomas Weisel Overweight Market Weight 06/02/2009 7.00
    Brean Murray — Buy 05/19/2009 10.00
    Roth Capital — Buy 03/06/2009 8.00
    Robert W. Baird Outperform Neutral 03/05/2009 5.00
    Oppenheimer Outperform Perform 02/05/2009 —
    Roth Capital — Buy 02/03/2009 9.00
    Roth Capital — Buy 11/24/2008 —
    Stanford Research — Buy 09/24/2008 13.00
    Roth Capital — Buy 09/08/2008 13.50
    Roth Capital — Buy 05/20/2008 14.00
    Susquehanna Financial — Positive 05/06/2008 16.00
    Oppenheimer Perform Outperform 03/05/2008 15.00
    Susquehanna Financial — Positive 10/22/2007 —
    CIBC Wrld Mkts Sector Outperform Sector Perform 05/08/2007 16.00
    Robert W. Baird Neutral Outperform 05/08/2007 19.00
    Robert W. Baird Outperform Neutral 02/27/2007 14.00
    Thomas Weisel — Overweight 01/23/2007 14.00
    Robert W. Baird — Outperform 01/23/2007 13.00
    JP Morgan — Overweight 01/23/2007 —
    CIBC Wrld Mkts — Sector Outperform 01/23/2007 14.00